Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Aubreyon Dec 08, 2016 2:44pm

128 Views

Post# 25573123

RE:Big Pharma, Short on Blockbusters, Outsources the Science

I suspect a partnership is around the corner, sooner than later, given the lofty goals of the new pipeline.
How much can little TLT handle...and as Ben's headline says, BP is short of blockbusters.
This type of oportunity doesn't come along every day.

low development costs, short duration of trials, cost to benefit odds looks outstanding.

partnership coming sooner than later? comments?

Bullboard Posts

Rig Count Soars as Utilization Surpasses Industry Averages